- Previous Close
10.28 - Open
10.23 - Bid 10.47 x --
- Ask 10.49 x --
- Day's Range
9.98 - 10.54 - 52 Week Range
7.47 - 11.41 - Volume
8,417,802 - Avg. Volume
3,712,370 - Market Cap (intraday)
3.609B - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
95.36 - EPS (TTM)
0.11 - Earnings Date --
- Forward Dividend & Yield 0.10 (0.92%)
- Ex-Dividend Date Jul 16, 2024
- 1y Target Est
--
Zhejiang Jianfeng Group Co., Ltd. operates in the cement business in China. It offers ordinary Portland, Portland slag, and other cement products. The company also provides medical products, including sodium hyaluronate eye drops for dry eyes; calculus bovis factitious; Henopokan for patients with severe herpes zoster; and yu feng ning xin di wan for high blood pressure, dizziness, headache, neck pain, coronary heart disease, angina, nervous headache, and early sudden deafness. In addition, it offers health products comprising broken fungus spore powder, lyophilized Tianma pieces, Sangge tea, black soya bean drinks, astragalus tablets, bomb sugar, and boiling Jade Kim tea bags, as well as goodnight, bone Thai, vitamin E nutritional, Tianfu, and grape seed extract soft capsules. Further, the company provides cable products, such as SYWV-75 series physical foamed cables; RVV series cables; network lines; HYA series, which are copper core solid polyolefin insulated tidal-sheathing city communication cables; and BV line ordinary insulated and household wires. Additionally, it offers warehousing, logistics distribution, freight forwarding declaration, international trade, and other services. The company was founded in 1958 and is based in Jinhua, China.
www.jianfeng.com.cn1,978
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 600668.SS
View MorePerformance Overview: 600668.SS
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600668.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600668.SS
View MoreValuation Measures
Market Cap
3.54B
Enterprise Value
3.84B
Trailing P/E
93.45
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.22
Price/Book (mrq)
0.70
Enterprise Value/Revenue
1.35
Enterprise Value/EBITDA
33.01
Financial Highlights
Profitability and Income Statement
Profit Margin
1.26%
Return on Assets (ttm)
0.46%
Return on Equity (ttm)
0.80%
Revenue (ttm)
2.85B
Net Income Avi to Common (ttm)
35.89M
Diluted EPS (ttm)
0.11
Balance Sheet and Cash Flow
Total Cash (mrq)
248.8M
Total Debt/Equity (mrq)
10.16%
Levered Free Cash Flow (ttm)
178.5M